FOXO4-DRI (Forkhead Box O4-D-Retro-Inverso) is a rationally designed synthetic peptide that functions as a selective senolytic agent, specifically targeting senescent cells for elimination while leaving healthy cells unharmed
To the extent viscosity considerations potentially limit the use of a syringe/needle delivery system, thermoreversible gels or post-administration viscosity-enhancing options are also envisioned, as well as alternative delivery systems, including pumps, microinjection devices and the like
The incidence of AF in our study was close to a previous cohort study (39 per 10,000 patient-years vs 32 per 10,000 patient-years) [26]
However, Larger particles tend to accumulate less and are cleared more efficiently [100]
Oarsi guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis